Oxybutynin Chloride
Product Images NDC 43353-367

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 43353-367). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Bottle Label 5mg (43353 367)

Bottle Label 5mg (43353 367)
Label for Oxybutynin Chloride 5 mg tablets, containing 90 tablets. The label includes storage instructions, manufacturer Vintage Pharmaceuticals LLC in Huntsville, AL, and repackager Aphena Pharma Solutions - Tennessee, LLC in Cookeville, TN. The product is marked RX only and includes barcodes and space for batch and lot numbers.*
FDA Label Image

Aphena Pharma Solutions (TN)

Aphena Pharma Solutions (TN)
FDA Label Image

This Is An Image Of The Structural Formula For Oxybutynin Chloride. (Oxybut 1)

This Is An Image Of The Structural Formula For Oxybutynin Chloride. (Oxybut 1)
Chemical structure of oxybutynin hydrochloride, showing its molecular arrangement with distinct aromatic, ester, alkyne, and amine functional groups.*
FDA Label Image

Figure 1. Mean R-oxybutynin Plasma Concentrations Following Three Doses Of Oxybutynin Chloride 5 mg Administered Every 8 Hours For 1 Day In 23 Healthy Adult Volunteers (Oxybut 2)

Figure 1. Mean R-oxybutynin Plasma Concentrations Following Three Doses Of Oxybutynin Chloride 5 mg Administered Every 8 Hours For 1 Day In 23 Healthy Adult Volunteers (Oxybut 2)
A line graph depicting mean plasma R-oxybutynin concentration (ng/mL) over time (hours) following dosing of Oxybutynin 5 mg three times daily (TID). Concentrations peak shortly after each dose, with values decreasing before the next dose, illustrating the pharmacokinetic profile over a 24-hour period.*
FDA Label Image

Figure 2.mean Steady-state (±sd) R-oxybutynin Plasma Concentrations Following Administration Of Total Daily Oxybutynin Chloride Tablet Dose Of 7.5 mg To 15 mg (0.22 mg/kg To 0.53 mg/kg) In Children 5‑15 Years Of Age. – Plot Represents All Available Data Normalized To The Equivalent Of Oxybutynin Chloride 5 mg Bid Or Tid At Steady State (Oxybut 3)

Figure 2.mean Steady-state (±sd) R-oxybutynin Plasma Concentrations Following Administration Of Total Daily Oxybutynin Chloride Tablet Dose Of 7.5 mg To 15 mg (0.22 mg/kg To 0.53 mg/kg) In Children 5‑15 Years Of Age. – Plot Represents All Available Data Normalized To The Equivalent Of Oxybutynin Chloride 5 mg Bid Or Tid At Steady State (Oxybut 3)
A line graph showing mean R-Oxybutynin plasma concentration (ng/mL) over time (hours). Concentration peaks around 1 hour and then declines steadily, with data points at 0, 1, 2, 4, 8, and 12 hours. Error bars indicate variability at each point.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.